0673.HK
Get informed when a big investor buys or sells
+ FollowOvervalued by 187.1% based on the discounted cash flow analysis.
| Market cap | $423.08 Million |
|---|---|
| Enterprise Value | $406.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.05 |
| Beta | -1.14 |
| Outstanding Shares | 1,386,310,000 |
| P/E Ratio | -6.21 |
|---|---|
| PEG | 24.4 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 5.08 |
| Enterprise Value to EBIT | -3.61 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.1 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Serving as an investment holding company, China Health Group Limited engages in a diverse range of operations. Within the People's Republic of China, its core business involves the supply and maintenance of medical equipment and disposab...